Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3785275rdf:typepubmed:Citationlld:pubmed
pubmed-article:3785275lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:3785275lifeskim:mentionsumls-concept:C1752930lld:lifeskim
pubmed-article:3785275lifeskim:mentionsumls-concept:C0047983lld:lifeskim
pubmed-article:3785275pubmed:issue3lld:pubmed
pubmed-article:3785275pubmed:dateCreated1986-12-31lld:pubmed
pubmed-article:3785275pubmed:abstractTextAdministration of 4-acetylaminofluorene (4AAF) to rats by oral gavage (1000 mg/kg) produces a wave of S-phase activity in the liver 36 h later, followed by a wave of mitoses at 48 h. These events were monitored by autoradiography of isolated hepatocytes and by histopathology, respectively. DNA-labelling was shown to occur following both in vivo and in vitro radiolabelling. The level of S-phases observed approached that reported following partial hepatectomy. These effects were not accompanied by unscheduled DNA synthesis (UDS) nor was any frank histopathological damage to the liver evident. 2-Acetylaminofluorene (2AAF) elicited a very weak S-phase response at a dose level of 50 mg/kg, but gave marked UDS between 12 and 48 h.lld:pubmed
pubmed-article:3785275pubmed:languageenglld:pubmed
pubmed-article:3785275pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3785275pubmed:citationSubsetIMlld:pubmed
pubmed-article:3785275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3785275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3785275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3785275pubmed:statusMEDLINElld:pubmed
pubmed-article:3785275pubmed:monthDeclld:pubmed
pubmed-article:3785275pubmed:issn0027-5107lld:pubmed
pubmed-article:3785275pubmed:authorpubmed-author:AshbyJJlld:pubmed
pubmed-article:3785275pubmed:authorpubmed-author:BeijeBBlld:pubmed
pubmed-article:3785275pubmed:authorpubmed-author:LefevreP APAlld:pubmed
pubmed-article:3785275pubmed:authorpubmed-author:BurlinsonBBlld:pubmed
pubmed-article:3785275pubmed:issnTypePrintlld:pubmed
pubmed-article:3785275pubmed:volume172lld:pubmed
pubmed-article:3785275pubmed:ownerNLMlld:pubmed
pubmed-article:3785275pubmed:authorsCompleteYlld:pubmed
pubmed-article:3785275pubmed:pagination271-9lld:pubmed
pubmed-article:3785275pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:meshHeadingpubmed-meshheading:3785275-...lld:pubmed
pubmed-article:3785275pubmed:year1986lld:pubmed
pubmed-article:3785275pubmed:articleTitlePotent mitogenic activity of 4-acetylaminofluorene to the rat liver.lld:pubmed
pubmed-article:3785275pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3785275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3785275lld:pubmed